Mireille Sanders
Director de Operaciones en PHARMING GROUP N.V. .
Fortuna: 711 711 $ al 31/05/2024
Perfil
Mireille Sanders is currently the Chief Operations Officer at Pharming Group NV.
Previously, she worked at Janssen Pharmaceuticals, Inc. as the Head-Clinical Supply Chain Strategic from 2016 to 2019.
Ms. Sanders is a graduate of Technische Universiteit Eindhoven.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PHARMING GROUP NV
0.12% | 31/03/2024 | 799 020 ( 0.12% ) | 711 711 $ | 31/05/2024 |
Cargos activos de Mireille Sanders
| Empresas | Cargo | Inicio |
|---|---|---|
| PHARMING GROUP N.V. | Director de Operaciones | 15/12/2020 |
Antiguos cargos conocidos de Mireille Sanders.
| Empresas | Cargo | Fin |
|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01/01/2019 |
Formación de Mireille Sanders.
| Technische Universiteit Eindhoven | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Mireille Sanders
